Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.2100
-0.2900 (-58.00%)
Mar 25, 2026, 3:51 PM EST
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $2.06 million as of March 26, 2026. Its market cap has decreased by -71.52% in one year.
Market Cap
2.06M
Enterprise Value
19.12M
Revenue
899.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.21
Market Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 2.06M, an increase of 716.00%. That is a compound annual growth rate of 14.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 2.06M | 110.00% |
| Dec 31, 2025 | 982.83K | -90.00% |
| Dec 31, 2024 | 9.83M | -38.42% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaccinex | 2.81M |
| Clearside Biomedical | 2.67M |
| AXIM Biotechnologies | 2.49M |
| VitaSpring Biomedical | 2.30M |
| Exousia Pro | 2.04M |
| LakeShore Biopharma | 1.85M |
| ZyVersa Therapeutics | 1.78M |
| Agentix | 1.68M |